NAFTIN SUMMARY
Naftin® Cream, 1% contains the synthetic, broad-spectrum, antifungal agent naftifine hydrochloride. Naftin® Cream, 1% is for topical use only.
Naftin® Cream, 1% is indicated for the topical treatment of tinea pedis, tinea cruris and tinea corporis caused by the organisms Trichophyton rubrum, Trichophyton mentagrophytes, and Epidermophyton floccosum.
|
NEWS HIGHLIGHTS
Published Studies Related to Naftin (Naftifine)
A randomized, double-blind, vehicle-controlled efficacy and safety study of
naftifine 2% cream in the treatment of tinea pedis. [2011]
treatment for four weeks and vehicle were also evaluated as a positive control... CONCLUSION: Topical NAFT-2 for two weeks is safe and provides significantly
Does naftifine have anti-inflammatory properties? A double-blind comparative study with 1% clotrimazole/1% hydrocortisone in clinically diagnosed fungal infection of the skin. [1993.10]
In a multicentre, double-blind, randomized, parallel group study in general practice, 269 patients with clinically diagnosed fungal infection of the skin were treated with either naftifine (Exoderil) or 1% clotrimazole plus 1% hydrocortisone (CHC; Canesten HC) applied twice daily for 4 weeks... This study suggests that there is no clinical advantage in treating patients with clinically diagnosed fungal infection of the skin with an antimycotic/corticosteroid combination as opposed to naftifine alone.
Once-daily naftifine cream 1% in the treatment of tinea cruris and tinea corporis. [1990.07]
Seventy patients with tinea cruris or tinea corporis were treated with naftifine cream 1% or vehicle once daily for 4 weeks in this double-blind, randomized study. After two weeks, the patients using naftifine had a significantly higher mycologic cure rate than the vehicle-treated patients (79% vs...
In vitro and in vivo cutaneous penetration and antifungal activity of naftifine. [1989.10]
The topical antifungal agent naftifine has shown considerable potency against a broad spectrum of dermatophytes. In this study, an in vitro penetration test in human cadaver skin and an in vivo tape-stripping test were used to evaluate the penetration and antifungal activity of naftifine gel 1 percent and naftifine cream 1 percent compared with other antifungal agents...
A double-blind clinical trial of fenticonazole (2%) spray versus naftifine (1%) spray in patients with cutaneous mycoses. [1989]
A multi-centre, double-blind trial was carried out in 100 patients with cutaneous mycotic infections, confirmed by direct microscopy and/or culture, to compare the efficacy and tolerability of spray formulations of 2% fenticonazole and 1% naftifine. On entry, patients were allocated at random to receive once daily topical applications of one or other drug over a period of 2 to 4 weeks, treatment being stopped when patients had recovered or substantially improved...
Clinical Trials Related to Naftin (Naftifine)
Evaluate Safety and Efficacy of Naftifine Hydrochloride Gel 2% and Naftin� Gel 2% in Tinea Pedis [Completed]
Evaluate the Safety and Efficacy of Naftifine Hydrochloride Cream 2% and Naftin� Cream 2% in Patients With Tinea Pedis [Completed]
The objective of this study is to compare the efficacy and safety of the test formulation of
Naftifine Hydrochloride Cream 2% to Naftin® (Naftifine Hydrochloride) 2% Cream in a 6 week
study in patients with tinea pedis.
Evaluate the Clinical Equivalence of Two Naftifine HCl 1% Creams in Patients With Interdigital Tinea Pedis [Completed]
The objective of this study is to evaluate the efficacy and safety of the test formulation
of Naftifine HCl Cream 1% (Taro Pharmaceuticals Inc.) as compared to the already marketed
formulation Naftin® (Naftifine HCl) 1% Cream (Merz Pharmaceuticals) and placebo in patients
with tinea pedis and to show the superiority of the active treatments over placebo when
dosed once a day for 28 days.
Evaluation of Efficacy and Safety of Naftin 1% Cream in Adolescent Subjects With Tinea Cruris [Completed]
To see how well Naftin 1% cream works when applied once daily to the affected area. The
results will be compared to those using a placebo cream, which is a cream with no active
ingredient. Safety will also be measured.
An Open Label Pharmacokinetic Study of Naftin for Tinea Corporis [Recruiting]
This is an open label, multi-center, multi-application pharmacokinetic study in pediatric
subjects with tinea corporis.
|
